Omnicare OCR
-
Omnicare ( OCR ): Q1 EPS of $0.90 beats by $0.05. Revenue of $1.53B misses by $0.01B. (PR)
Omnicare ( OCR ): Q1 EPS of $0.90 beats by $0.05 . Revenue of $1.53B misses by $0.01B . ( PR ) Post your comment!
-
PharMerica (PMC) names David W. Froesel, Jr. as interim Chief Financial Officer, effective immediately. Mr. Froesel, who was CFO of Omnicare from 1996 to 2009, and succeeds Michael J. Culotta, who by ...
… names David W. Froesel, Jr. as interim Chief Financial Officer , effective immediately. Mr. Froesel, who was CFO of Omnicare from 1996 to 2009, and succeeds Michael J. Culotta, who by mutual agreement with the company, has stepped down to …
-
Omnicare ([[ OCR ]] -0.6%) slips despite a Q4 earnings beat across the board. Net earnings rose 89% as the nursing-home pharmacy company benefited from stronger margins and lower litigation-related ...
Omnicare ( OCR -0.6% ) slips despite a Q4 earnings beat across the board. Net earnings rose 89% as the nursing-home pharmacy company benefited …
-
Omnicare OCR Q4 2012 Earnings Call Transcript
… My name is Brant, and I will be your conference operator today. At this time, I would like to welcome everyone to Omnicare 's Fourth Quarter and Year End Conference Call. All lines have been placed on mute to prevent any background noise …
-
Omnicare ( OCR ): Q3 EPS of $0.86 beats by $0.13. Revenue of $1.5B (-2.8% Y/Y) misses by $40M. (PR)
Omnicare ( OCR ): Q3 EPS of $0.86 beats by $0.13 . Revenue of $1.5B (-2.8% Y/Y) misses by $40M . ( PR ) Post your comment!
-
BRIEF-Moody's assigns Baa3 ratings to Omnicare's amend and extend bank credit facilities; outlook stable
Sept 26 (Reuters) - Moody's assigns Baa3 ratings to Omnicare 's amend and extend bank credit facilities; outlook stable
-
Omnicare ( OCR ) yesterday named interim CEO John Workman to the top job permanently to replace John Figueroa, who left in June. Workman had been CFO at the company, which supplies nursing homes with ...
Omnicare ( OCR ) yesterday named interim CEO John Workman to the top job permanently ..... nursing homes with drugs, and so he'll be replaced by Robert Kraft. Omnicare also doubled its dividend to $0.14 a share and increased its buyback …
-
UPDATE 1- Omnicare CEO resigns, CFO to lead in interim
June 11 (Reuters) - Pharmacy operator Omnicare Inc said Chief Executive John Figueroa resigned, and it named finance chief John Workman as interim CEO.
-
Wall Street Breakfast: Must-Know News
… investigations into how it marketed its Risperdal antipsychotic treatment and other drugs, and claims it paid kickbacks to Omnicare ( OCR ), Bloomberg reports. Unlike with the banks, J&J will make a misdemeanor plea, with the deal including a criminal …
-
UPDATE 1- Omnicare settles DoJ probe for $50 mln
May 11 (Reuters) - Pharmacy operator Omnicare Inc said it will pay $50 million to settle an investigation by the U.S. Department of Justice (DoJ) concerning errors in the company's distribution of controlled substances.